{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:46:33Z","timestamp":1786981593142,"version":"build-2736575974"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009793","name":"Chapman University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alterations in drug transporters in acute liver failure and chronic liver diseases, such as cirrhosis, have been reviewed before. However, there is a lack of comprehensive reviews on how liver surgery, including transplantation and partial hepatectomy, affects drug transporters. Because ischemia\u2013reperfusion (IR) injury is a hallmark of liver transplantation and most other surgical procedures of the liver, this review focuses on the effects of IR injury, in addition to liver resection, on the expression and function of transporters in the liver and remote organs. Most of the reported studies in this area are carried out in animal models of liver surgeries, with relatively limited data in humans. The results indicate that the effects of IR injury and partial hepatectomy on drug transporters are complex and depend on many variables, such as the species, length and type of ischemia, reperfusion time, and the extent of liver resection. However, for a few major transporters, clear trends have emerged based on both animal and human studies. A major trend is that warm (normothermic) hepatic IR injury or liver transplantation causes overexpression of P-glycoprotein in the liver and remote organs, affecting the pharmacokinetics of substrate drugs. Another observed trend is the relocalization of the liver MRP2\/Mrp2 from the canalicular membranes to the cytoplasmic area, reducing the function of the transporter even in the absence of a change in its protein. Alterations in transporter function, such as P-glycoprotein, may significantly impact the pharmacokinetics and pharmacodynamics of drugs in patients undergoing liver surgeries.<\/jats:p>","DOI":"10.1007\/s11095-025-03901-8","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:51:22Z","timestamp":1753915882000},"page":"1231-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Liver Surgery on Drug Transporters in the Liver and Remote Organs"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1770-0391","authenticated-orcid":false,"given":"Reza","family":"Mehvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"3","key":"3901_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/HEP.0000000000000873","volume":"80","author":"S Feng","year":"2024","unstructured":"Feng S, Roll GR, Rouhani FJ, Sanchez FA. The future of liver transplantation. Hepatol. 2024;80(3):674\u201397.","journal-title":"Hepatol"},{"issue":"3","key":"3901_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/SLA.0000000000003463","volume":"270","author":"A Humar","year":"2019","unstructured":"Humar A, Ganesh S, Jorgensen D, Tevar A, Ganoza A, Molinari M, et al. Adult living donor versus deceased donor liver transplant (LDLT Versus DDLT) at a single center: Time to change our paradigm for liver transplant. Ann Surg. 2019;270(3):444\u201351.","journal-title":"Ann Surg"},{"issue":"2 Suppl 1","key":"3901_CR3","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.20969","volume":"43","author":"N Fausto","year":"2006","unstructured":"Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatol. 2006;43(2 Suppl 1):S45-53.","journal-title":"Hepatol"},{"key":"3901_CR4","doi-asserted-by":"crossref","unstructured":"Yagi S, Hirata M, Miyachi Y, Uemoto S. Liver regeneration after hepatectomy and partial liver transplantation. Int J Mol Sci. 2020;21(21):8414.","DOI":"10.3390\/ijms21218414"},{"issue":"5","key":"3901_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/FPC.0b013e3282f9ac01","volume":"18","author":"M Fukudo","year":"2008","unstructured":"Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, et al. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics. 2008;18(5):413\u201323.","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"3901_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1067\/mcp.2001.115142","volume":"69","author":"T Hashida","year":"2001","unstructured":"Hashida T, Masuda S, Uemoto S, Saito H, Tanaka K, Inui K. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther. 2001;69(5):308\u201316.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"3901_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1053\/jlts.2003.50179","volume":"9","author":"S Masuda","year":"2003","unstructured":"Masuda S, Goto M, Kiuchi T, Uemoto S, Kodawara T, Saito H, et al. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation. Liver Transpl. 2003;9(10):1108\u201313.","journal-title":"Liver Transpl"},{"issue":"10","key":"3901_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/00007890-200211270-00014","volume":"74","author":"T Shimada","year":"2002","unstructured":"Shimada T, Terada A, Yokogawa K, Kaneko H, Nomura M, Kaji K, et al. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. Transplant. 2002;74(10):1419\u201324.","journal-title":"Transplant"},{"issue":"3","key":"3901_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","volume":"62","author":"KS Lown","year":"1997","unstructured":"Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther. 1997;62(3):248\u201360.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"3901_CR10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1097\/00007890-200206150-00021","volume":"73","author":"P Grude","year":"2002","unstructured":"Grude P, Boleslawski E, Conti F, Chouzenoux S, Calmus Y. MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. Transplant. 2002;73(11):1824\u20138.","journal-title":"Transplant"},{"issue":"2","key":"3901_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/jpet.107.135665","volume":"325","author":"M Goto","year":"2008","unstructured":"Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Tanaka K, et al. Relation between mRNA expression level of multidrug resistance 1\/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation. J Pharmacol Exp Ther. 2008;325(2):610\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3901_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin invest. 1995;96(4):1698\u2013705.","journal-title":"J Clin invest"},{"issue":"8","key":"3901_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1023\/A:1018993312773","volume":"16","author":"K Yokogawa","year":"1999","unstructured":"Yokogawa K, Takahashi M, Tamai I, Konishi H, Nomura M, Moritani S, et al. P-glycoprotein-dependent disposition kinetics of tacrolimus: Studies in mdr1a knockout mice. Pharm Res. 1999;16(8):1213\u20138.","journal-title":"Pharm Res"},{"issue":"3\u20134","key":"3901_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.trim.2008.05.009","volume":"19","author":"J Wang","year":"2008","unstructured":"Wang J, Figurski M, Shaw LM, Burckart GJ. The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice. Transpl Immunol. 2008;19(3\u20134):192\u20136.","journal-title":"Transpl Immunol"},{"issue":"1","key":"3901_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/FPC.0000000000000010","volume":"24","author":"V Lamba","year":"2014","unstructured":"Lamba V, Sangkuhl K, Sanghavi K, Fish A, Altman RB, Klein TE. PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014;24(1):73\u20139.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"3901_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/clpt.2009.205","volume":"87","author":"N Picard","year":"2010","unstructured":"Picard N, Yee SW, Woillard JB, Lebranchu Y, Le Meur Y, Giacomini KM, et al. The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther. 2010;87(1):100\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"3901_CR17","doi-asserted-by":"crossref","unstructured":"Fan Y, Liu X. Alterations in expression and function of ABC family transporters at blood-brain barrier under liver failure and their clinical significances. Pharmaceutics. 2018;10(3):102.","DOI":"10.3390\/pharmaceutics10030102"},{"issue":"9","key":"3901_CR18","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.xphs.2017.04.053","volume":"106","author":"N Thakkar","year":"2017","unstructured":"Thakkar N, Slizgi JR, Brouwer KLR. Effect of liver disease on hepatic transporter expression and function. J Pharm Sci. 2017;106(9):2282\u201394.","journal-title":"J Pharm Sci"},{"issue":"4","key":"3901_CR19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/bcp.15990","volume":"90","author":"S Armani","year":"2024","unstructured":"Armani S, Geier A, Forst T, Merle U, Alpers DH, Lunnon MW. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactions. Br J Clin Pharmacol. 2024;90(4):942\u201358.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3901_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1517\/17425255.2016.1139575","volume":"12","author":"M Li","year":"2016","unstructured":"Li M, Zhao Y, Humar A, Tevar AD, Hughes C, Venkataramanan R. Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans. Expert Opin Drug Metab Toxicol. 2016;12(3):231\u201343.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"3901_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/lt.26517","volume":"29","author":"R Morales Junior","year":"2023","unstructured":"Morales Junior R, Telles JP, Kwiatkowski SY, Juodinis VD, de Souza DC, Santos S. Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients. Liver Transpl. 2023;29(1):91\u2013102.","journal-title":"Liver Transpl"},{"issue":"3","key":"3901_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0016-5085(03)01048-5","volume":"125","author":"N Selzner","year":"2003","unstructured":"Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterol. 2003;125(3):917\u201336.","journal-title":"Gastroenterol"},{"issue":"2","key":"3901_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0014-4800(03)00008-X","volume":"74","author":"C Fondevila","year":"2003","unstructured":"Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia\/reperfusion injury\u2013a fresh look. Exp Mol Pathol. 2003;74(2):86\u201393.","journal-title":"Exp Mol Pathol"},{"key":"3901_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev.pharmtox.37.1.327","volume":"37","author":"JJ Lemasters","year":"1997","unstructured":"Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol. 1997;37:327\u201338.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"3901_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/00007890-198804000-00001","volume":"45","author":"FO Belzer","year":"1988","unstructured":"Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplant. 1988;45(4):673\u20136.","journal-title":"Transplant"},{"issue":"2","key":"3901_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-2007-1007108","volume":"19","author":"SN Lichtman","year":"1999","unstructured":"Lichtman SN, Lemasters JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis. 1999;19(2):171\u201387.","journal-title":"Semin Liver Dis"},{"key":"3901_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/liv.14091","volume":"39","author":"WA Dar","year":"2019","unstructured":"Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int. 2019;39:788\u2013801.","journal-title":"Liver Int"},{"issue":"1","key":"3901_CR28","doi-asserted-by":"publisher","first-page":"G15","DOI":"10.1152\/ajpgi.00342.2002","volume":"284","author":"H Jaeschke","year":"2003","unstructured":"Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G15\u201326.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"3901_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S0016-5085(03)01209-5","volume":"125","author":"H Jaeschke","year":"2003","unstructured":"Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia\/reperfusion injury. Gastroenterol. 2003;125(4):1246\u201357.","journal-title":"Gastroenterol"},{"issue":"3","key":"3901_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08941930390205773","volume":"16","author":"H Jaeschke","year":"2003","unstructured":"Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg. 2003;16(3):127\u201340.","journal-title":"J Invest Surg"},{"issue":"12","key":"3901_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/17425250903304056","volume":"5","author":"O Fardel","year":"2009","unstructured":"Fardel O, Le Vee M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin Drug Metab Toxicol. 2009;5(12):1469\u201381.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"3901_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1124\/dmd.107.016907","volume":"36","author":"M Le Vee","year":"2008","unstructured":"Le Vee M, Gripon P, Stieger B, Fardel O. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos. 2008;36(2):217\u201322.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3901_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1053\/jhep.2003.50317","volume":"38","author":"A Geier","year":"2003","unstructured":"Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatol. 2003;38(2):345\u201354.","journal-title":"Hepatol"},{"issue":"1","key":"3901_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1124\/jpet.123.002019","volume":"391","author":"T Hao","year":"2024","unstructured":"Hao T, Tsang YP, Yin M, Mao Q, Unadkat JD. Dysregulation of human hepatic drug transporters by proinflammatory cytokines. J Pharmacol Exp Ther. 2024;391(1):82\u201390.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"3901_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0162-3109(00)00271-X","volume":"1","author":"G Hartmann","year":"2001","unstructured":"Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1(2):189\u201399.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3901_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/(SICI)1097-4652(199809)176:3<506::AID-JCP7>3.0.CO;2-S","volume":"176","author":"KI Hirsch-Ernst","year":"1998","unstructured":"Hirsch-Ernst KI, Ziemann C, Foth H, Kozian D, Schmitz-Salue C, Kahl GF. Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures. J Cell Physiol. 1998;176(3):506\u201315.","journal-title":"J Cell Physiol"},{"issue":"3","key":"3901_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/carcin\/20.3.407","volume":"20","author":"C Ziemann","year":"1999","unstructured":"Ziemann C, Burkle A, Kahl GF, Hirsch-Ernst KI. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis. 1999;20(3):407\u201314.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3901_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1074\/jbc.M004551200","volume":"276","author":"L Deng","year":"2001","unstructured":"Deng L, Lin-Lee YC, Claret FX, Kuo MT. 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem. 2001;276(1):413\u201320.","journal-title":"J Biol Chem"},{"issue":"5","key":"3901_CR39","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","volume":"59","author":"C Peralta","year":"2013","unstructured":"Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094\u2013106.","journal-title":"J Hepatol"},{"issue":"3","key":"3901_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1213\/ane.0b013e3181616fc9","volume":"106","author":"N Bedirli","year":"2008","unstructured":"Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 2008;106(3):830\u20137.","journal-title":"Anesth Analg"},{"issue":"2","key":"3901_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000093300","volume":"38","author":"E Ofluoglu","year":"2006","unstructured":"Ofluoglu E, Kerem M, Pasaoglu H, Turkozkan N, Seven I, Bedirli A, et al. Delayed energy protection of ischemic preconditioning on hepatic ischemia\/reperfusion injury in rats. Eur Surg Res. 2006;38(2):114\u201321.","journal-title":"Eur Surg Res"},{"key":"3901_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jss.2008.02.064","volume":"153","author":"D Ban","year":"2009","unstructured":"Ban D, Kudo A, Sui S, Tanaka S, Nakamura N, Ito K, et al. Decreased Mrp2-dependent bile flow in the post-warm ischemic rat liver. J Surg Res. 2009;153:310\u20136.","journal-title":"J Surg Res"},{"key":"3901_CR43","doi-asserted-by":"publisher","first-page":"298657","DOI":"10.1155\/2012\/298657","volume":"2012","author":"M Mendes-Braz","year":"2012","unstructured":"Mendes-Braz M, Elias-Miro M, Jimenez-Castro MB, Casillas-Ramirez A, Ramalho FS, Peralta C. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol. 2012;2012:298657.","journal-title":"J Biomed Biotechnol"},{"key":"3901_CR44","doi-asserted-by":"crossref","unstructured":"Abe Y, Hines IN, Zibari G, Pavlick K, Gray L, Kitagawa Y, et al. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med. 2009;46(1):1\u20137.","DOI":"10.1016\/j.freeradbiomed.2008.09.029"},{"key":"3901_CR45","doi-asserted-by":"crossref","unstructured":"Karatzas T, Neri AA, Baibaki ME, Dontas IA. Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms. J Surg Res. 2014;191(2):399\u2013412.","DOI":"10.1016\/j.jss.2014.06.024"},{"issue":"2","key":"3901_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08941930600569704","volume":"19","author":"HU Spiegel","year":"2006","unstructured":"Spiegel HU, Bahde R. Experimental models of temporary normothermic liver ischemia. J Invest Surg. 2006;19(2):113\u201323.","journal-title":"J Invest Surg"},{"issue":"6","key":"3901_CR47","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1023\/B:PHAM.0000029290.54167.7c","volume":"21","author":"AP Chimalakonda","year":"2004","unstructured":"Chimalakonda AP, Mehvar R. Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers. Pharm Res. 2004;21(6):1000\u20138.","journal-title":"Pharm Res"},{"issue":"7","key":"3901_CR48","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1023\/A:1024402121053","volume":"20","author":"AP Chimalakonda","year":"2003","unstructured":"Chimalakonda AP, Mehvar R. Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug. Pharm Res. 2003;20(7):1001\u20138.","journal-title":"Pharm Res"},{"issue":"12","key":"3901_CR49","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s11095-007-9414-1","volume":"24","author":"AP Chimalakonda","year":"2007","unstructured":"Chimalakonda AP, Mehvar R. Effects of methylprednisolone and its liver-targeted dextran prodrug on ischemia-reperfusion injury in a rat liver transplantation model. Pharm Res. 2007;24(12):2231\u20138.","journal-title":"Pharm Res"},{"issue":"2","key":"3901_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/jhep.2000.8896","volume":"32","author":"M Arai","year":"2000","unstructured":"Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage\/reperfusion injury in rat livers. Hepatology. 2000;32(2):297\u2013302.","journal-title":"Hepatology"},{"issue":"4","key":"3901_CR51","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00007890-198804000-00041","volume":"45","author":"JC Caldwell-Kenkel","year":"1988","unstructured":"Caldwell-Kenkel JC, Thurman RG, Lemasters JJ. Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers. Transplant. 1988;45(4):834\u20137.","journal-title":"Transplant"},{"key":"3901_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-981-13-7647-4_3","volume":"1141","author":"X Liu","year":"2019","unstructured":"Liu X. SLC family transporters. Adv Exp Med Biol. 2019;1141:101\u2013202.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"3901_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2217\/14622416.9.5.597","volume":"9","author":"ZM Zair","year":"2008","unstructured":"Zair ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA. Pharmacogenetics of OATP (SLC21\/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics. 2008;9(5):597\u2013624.","journal-title":"Pharmacogenomics"},{"key":"3901_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-981-13-7647-4_6","volume":"1141","author":"G Pan","year":"2019","unstructured":"Pan G. Roles of hepatic drug transporters in drug disposition and liver toxicity. Adv Exp Med Biol. 2019;1141:293\u2013340.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"3901_CR55","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/hep.21596","volume":"45","author":"HJ Shin","year":"2007","unstructured":"Shin HJ, Anzai N, Enomoto A, He X, Kim DK, Endou H, et al. Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatol. 2007;45(4):1046\u201355.","journal-title":"Hepatol"},{"key":"3901_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10254-003-0017-x","volume":"150","author":"H Koepsell","year":"2003","unstructured":"Koepsell H, Schmitt BM, Gorboulev V. Organic cation transporters. Rev Physiol Biochem Pharmacol. 2003;150:36\u201390.","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"7","key":"3901_CR57","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","volume":"24","author":"H Koepsell","year":"2007","unstructured":"Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24(7):1227\u201351.","journal-title":"Pharm Res"},{"key":"3901_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-13-7647-4_2","volume":"1141","author":"X Liu","year":"2019","unstructured":"Liu X. ABC family transporters. Adv Exp Med Biol. 2019;1141:13\u2013100.","journal-title":"Adv Exp Med Biol"},{"key":"3901_CR59","doi-asserted-by":"crossref","unstructured":"Theodoraki K, Arkadopoulos N, Nastos C, Vassiliou I, Karmaniolou I, Smyrniotis V. Small liver remnants are more vulnerable to ischemia\/reperfusion injury after extended hepatectomies: a case-control study. World J Surg. 2012;36(12):2895\u2013900.","DOI":"10.1007\/s00268-012-1779-6"},{"issue":"3","key":"3901_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.tpj.6500413","volume":"7","author":"GD Leschziner","year":"2007","unstructured":"Leschziner GD, Andrew T, Pirmohamed M, Johnson MR. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J. 2007;7(3):154\u201379.","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"3901_CR61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2005.03.017","volume":"43","author":"C Pauli-Magnus","year":"2005","unstructured":"Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005;43(2):342\u201357.","journal-title":"J Hepatol"},{"issue":"2","key":"3901_CR62","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1124\/jpet.105.084830","volume":"314","author":"M Hirano","year":"2005","unstructured":"Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y. Bile salt export pump (BSEP\/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther. 2005;314(2):876\u201382.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"3901_CR63","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1124\/mol.107.041459","volume":"73","author":"S Matsushima","year":"2008","unstructured":"Matsushima S, Maeda K, Hayashi H, Debori Y, Schinkel AH, Schuetz JD, et al. Involvement of multiple efflux transporters in hepatic disposition of fexofenadine. Mol Pharmacol. 2008;73(5):1474\u201383.","journal-title":"Mol Pharmacol"},{"key":"3901_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jss.2018.09.057","volume":"235","author":"J Kim","year":"2019","unstructured":"Kim J, Martin A, Yee J, Fojut L, Geurts AM, Oshima K, et al. Effects of hepatic ischemia-reperfusion injuries and NRF2 on transcriptional activities of bile transporters in rats. J Surg Res. 2019;235:73\u201382.","journal-title":"J Surg Res"},{"issue":"2","key":"3901_CR65","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/01.tp.0000226243.69023.54","volume":"82","author":"Y Tanaka","year":"2006","unstructured":"Tanaka Y, Chen C, Maher JM, Klaassen CD. Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. Transplant. 2006;82(2):258\u201366.","journal-title":"Transplant"},{"issue":"4","key":"3901_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11095-013-1208-z","volume":"31","author":"MK Miah","year":"2014","unstructured":"Miah MK, Shaik IH, Bickel U, Mehvar R. Effects of hepatic ischemia-reperfusion injury on the P-glycoprotein activity at the liver canalicular membrane and blood-brain barrier determined by in vivo administration of rhodamine 123 in rats. Pharm Res. 2014;31(4):861\u201373.","journal-title":"Pharm Res"},{"issue":"10","key":"3901_CR67","doi-asserted-by":"publisher","first-page":"101306","DOI":"10.1117\/1.JBO.18.10.101306","volume":"18","author":"CA Thorling","year":"2013","unstructured":"Thorling CA, Liu X, Burczynski FJ, Fletcher LM, Roberts MS, Sanchez WY. Intravital multiphoton microscopy can model uptake and excretion of fluorescein in hepatic ischemia-reperfusion injury. J Biomed Opt. 2013;18(10):101306.","journal-title":"J Biomed Opt"},{"issue":"11","key":"3901_CR68","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1053\/jlts.2003.50232","volume":"9","author":"L Accatino","year":"2003","unstructured":"Accatino L, Pizarro M, Solis N, Arrese M, Koenig CS. Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat. Liver Transpl. 2003;9(11):1199\u2013210.","journal-title":"Liver Transpl"},{"key":"3901_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/toxsci\/kfm261","volume":"101","author":"Y Tanaka","year":"2008","unstructured":"Tanaka Y, Chen C, Maher JM, Klaassen CD. Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). Toxicol Sci. 2008;101:171\u20138.","journal-title":"Toxicol Sci"},{"issue":"1","key":"3901_CR70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.18433\/J33C7B","volume":"17","author":"CA Thorling","year":"2014","unstructured":"Thorling CA, Roberts MS, Liu X, Fletcher LM, Crawford D, Burczynski FJ. Effects of long-term hepatic ischemia-reperfusion injury on the function of P-glycoprotein in vivo in rats. J Pharm Pharm Sci. 2014;17(1):121\u201335.","journal-title":"J Pharm Pharm Sci"},{"key":"3901_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1124\/jpet.108.145581","volume":"328","author":"K Ikemura","year":"2009","unstructured":"Ikemura K, Urano K, Matsuda H, Mizutani H, Iwamoto T, Okuda M. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: The contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells. J Pharmacol Exp Ther. 2009;328:249\u201355.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"3901_CR72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.18433\/J3MS40","volume":"15","author":"R Parasrampuria","year":"2012","unstructured":"Parasrampuria R, Shaik IH, Mehvar R. Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers. J Pharm Pharm Sci. 2012;15(2):318\u201328.","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"3901_CR73","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3325\/cmj.2023.64.391","volume":"64","author":"B Guven","year":"2023","unstructured":"Guven B, Tanoglu A, Ozcelik F, Tanoglu EG, Terzi NK. 4-phenyl butyric acid improves hepatic ischemia\/reperfusion and affects gene expression of ABC transporter Abcc5 in rats. Croat Med J. 2023;64(6):391\u2013403.","journal-title":"Croat Med J"},{"issue":"Aug 27","key":"3901_CR74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.brainres.2015.05.038","volume":"1618","author":"MK Miah","year":"2015","unstructured":"Miah MK, Shaik IH, Bickel U, Mehvar R. Effects of Pringle maneuver and partial hepatectomy on the pharmacokinetics and blood-brain barrier permeability of sodium fluorescein in rats. Brain Res. 2015;1618(Aug 27):249\u201360.","journal-title":"Brain Res"},{"key":"3901_CR75","doi-asserted-by":"crossref","unstructured":"Sui S, Kudo A, Suematsu M, Tanaka S, Nakamura N, Ito K, et al. Preservation solutions alter Mrp2-dependent bile flow in cold ischemic rat livers. J Surg Res. 2010;159(1);572\u201381.","DOI":"10.1016\/j.jss.2008.12.043"},{"issue":"11","key":"3901_CR76","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s11095-022-03384-x","volume":"39","author":"OA Almazroo","year":"2022","unstructured":"Almazroo OA, Shaik IH, Hughes CB, Humar A, Venkataramanan R. Treprostinil supplementation ameliorates hepatic ischemia reperfusion injury and regulates expression of hepatic drug transporters: An isolated perfused rat liver (IPRL) study. Pharm Res. 2022;39(11):2979\u201390.","journal-title":"Pharm Res"},{"issue":"4","key":"3901_CR77","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/hep.20104","volume":"39","author":"A Kudo","year":"2004","unstructured":"Kudo A, Kashiwagi S, Kajimura M, Yoshimura Y, Uchida K, Arii S, et al. Kupffer cells alter organic anion transport through multidrug resistance protein 2 in the post-cold ischemic rat liver. Hepatol. 2004;39(4):1099\u2013109.","journal-title":"Hepatol"},{"key":"3901_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1515\/hsz-2012-0153","volume":"394","author":"M Donner","year":"2012","unstructured":"Donner M, Topp SA, Cebula P, Krienen A, Gehrmann T, Sommerfeld A, et al. HbG200-mediated preinduction of heme oxygenase-1 improves bile flow and ameliorates pericentral downregulation of Bsep and Mrp2 following experimental liver ischemia and reperfusion. Biol Chem. 2012;394:97\u2013112.","journal-title":"Biol Chem"},{"issue":"1","key":"3901_CR79","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1152\/ajpgi.00175.2006","volume":"293","author":"L Fouassier","year":"2007","unstructured":"Fouassier L, Beaussier M, Schiffer E, Rey C, Barbu V, Mergey M, et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):G25-35.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3901_CR80","doi-asserted-by":"crossref","unstructured":"Monti CE, Hong SK, Audi SH, Lee W, Joshi A, Terhune SS, et al. Assessing the degree of hepatic ischemia-reperfusion injury using PBPK modeling of sodium fluorescein disposition in ex vivo machine-perfused livers. Am J Physiol Gastrointest Liver Physiol. 2024;327(3):G424\u2013G437.","DOI":"10.1152\/ajpgi.00048.2024"},{"issue":"3","key":"3901_CR81","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/TP.0b013e3181954fee","volume":"87","author":"G Chen","year":"2009","unstructured":"Chen G, Wang S, Bie P, Li X, Dong J. Endogenous bile salts are associated with bile duct injury in the rat liver transplantation model. Transplant. 2009;87(3):330\u20139.","journal-title":"Transplant"},{"issue":"3","key":"3901_CR82","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/dmd.104.001669","volume":"33","author":"PP Annaert","year":"2005","unstructured":"Annaert PP, Brouwer KL. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metab Dispos. 2005;33(3):388\u201394.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3901_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mc.2940080202","volume":"8","author":"LD Teeter","year":"1993","unstructured":"Teeter LD, Estes M, Chan JY, Atassi H, Sell S, Becker FF, et al. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog. 1993;8(2):67\u201373.","journal-title":"Mol Carcinog"},{"issue":"3 Pt 1","key":"3901_CR84","first-page":"G621","volume":"273","author":"RM Green","year":"1997","unstructured":"Green RM, Gollan JL, Hagenbuch B, Meier PJ, Beier DR. Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol. 1997;273(3 Pt 1):G621\u20137.","journal-title":"Am J Physiol"},{"issue":"6","key":"3901_CR85","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/S0016-5085(99)70291-X","volume":"117","author":"T Gerloff","year":"1999","unstructured":"Gerloff T, Geier A, Stieger B, Hagenbuch B, Meier PJ, Matern S, et al. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterol. 1999;117(6):1408\u201315.","journal-title":"Gastroenterol"},{"issue":"2","key":"3901_CR86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jhep.2010.11.023","volume":"55","author":"T Miura","year":"2011","unstructured":"Miura T, Kimura N, Yamada T, Shimizu T, Nanashima N, Yamana D, et al. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy. J Hepatol. 2011;55(2):407\u201314.","journal-title":"J Hepatol"},{"issue":"1","key":"3901_CR87","first-page":"28","volume":"30","author":"N Kimura","year":"2012","unstructured":"Kimura N, Hakamada K, Ikenaga SK, Umehara Y, Toyoki Y, Sasaki M. Gene expression of ATP-binding cassette transporters during liver regeneration after 90% hepatectomy in rats. Int J Mol Med. 2012;30(1):28\u201334.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3901_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.TP.0000089234.93366.6D","volume":"77","author":"TH Chang","year":"2004","unstructured":"Chang TH, Hakamada K, Toyoki Y, Tsuchida S, Sasaki M. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats. Transplant. 2004;77(1):22\u20137.","journal-title":"Transplant"},{"issue":"4805","key":"3901_CR89","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.3576227","volume":"236","author":"SS Thorgeirsson","year":"1987","unstructured":"Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Sci. 1987;236(4805):1120\u20132.","journal-title":"Sci"},{"issue":"2","key":"3901_CR90","first-page":"57","volume":"1","author":"PA Marino","year":"1990","unstructured":"Marino PA, Gottesman MM, Pastan I. Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth Differ. 1990;1(2):57\u201362.","journal-title":"Cell Growth Differ"},{"issue":"6","key":"3901_CR91","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep.510290638","volume":"29","author":"TA Vos","year":"1999","unstructured":"Vos TA, Ros JE, Havinga R, Moshage H, Kuipers F, Jansen PL, et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatol. 1999;29(6):1833\u20139.","journal-title":"Hepatol"},{"issue":"3","key":"3901_CR92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1248\/bpb.26.303","volume":"26","author":"M Daoudaki","year":"2003","unstructured":"Daoudaki M, Fouzas I, Stapf V, Ekmekcioglu C, Imvrios G, Andoniadis A, et al. Cyclosporine a augments P-glycoprotein expression in the regenerating rat liver. Biol Pharm Bull. 2003;26(3):303\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"3901_CR93","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/gut.52.7.1060","volume":"52","author":"JE Ros","year":"2003","unstructured":"Ros JE, Roskams TA, Geuken M, Havinga R, Splinter PL, Petersen BE, et al. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut. 2003;52(7):1060\u20137.","journal-title":"Gut"},{"issue":"6","key":"3901_CR94","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1478-3231.2005.01158.x","volume":"25","author":"O Dransfeld","year":"2005","unstructured":"Dransfeld O, Gehrmann T, Kohrer K, Kircheis G, Holneicher C, Haussinger D, et al. Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver. Liver Int. 2005;25(6):1243\u201358.","journal-title":"Liver Int"},{"issue":"1","key":"3901_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfi053","volume":"84","author":"SS Villanueva","year":"2005","unstructured":"Villanueva SS, Ruiz ML, Luquita MG, Sanchez Pozzi EJ, Catania VA, Mottino AD. Involvement of Mrp2 in hepatic and intestinal disposition of dinitrophenyl-S-glutathione in partially hepatectomized rats. Toxicol Sci. 2005;84(1):4\u201311.","journal-title":"Toxicol Sci"},{"issue":"5","key":"3901_CR96","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/mc.2940040506","volume":"4","author":"LD Teeter","year":"1991","unstructured":"Teeter LD, Chan JY, Kuo MT. Coordinate activation of multidrug-resistance (P-glycoprotein) genes mdr2 and mdr3 during mouse liver regeneration. Mol Carcinog. 1991;4(5):358\u201361.","journal-title":"Mol Carcinog"},{"issue":"3","key":"3901_CR97","doi-asserted-by":"publisher","first-page":"G419","DOI":"10.1152\/ajpgi.90728.2008","volume":"297","author":"IL Csanaky","year":"2009","unstructured":"Csanaky IL, Aleksunes LM, Tanaka Y, Klaassen CD. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol. 2009;297(3):G419\u201333.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3901_CR98","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2012.06.031","volume":"690","author":"K Ikemura","year":"2012","unstructured":"Ikemura K, Inoue K, Mizutani H, Oka H, Iwamoto T, Okuda M. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine. Eur J Pharmacol. 2012;690:192\u2013201.","journal-title":"Eur J Pharmacol"},{"key":"3901_CR99","doi-asserted-by":"crossref","unstructured":"Ikemura K, Nakagawa E, Kurata T, Iwamoto T, Okuda M. Altered pharmacokinetics of cimetidine caused by down-regulation of renal rat organic cation transporter 2 (rOCT2) after liver ischemia-reperfusion injury. Drug Metab Pharmacokinet. 2013;28(6):504\u20139.","DOI":"10.2133\/dmpk.DMPK-13-RG-021"},{"issue":"11\u201312","key":"3901_CR100","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.lfs.2011.01.012","volume":"88","author":"A Yamauchi","year":"2011","unstructured":"Yamauchi A, Dohgu S, Takata F, Watanabe T, Nishioku T, Matsumoto J, et al. Partial hepatectomy aggravates cyclosporin A-induced neurotoxicity by lowering the function of the blood-brain barrier in mice. Life Sci. 2011;88(11\u201312):529\u201334.","journal-title":"Life Sci"},{"key":"3901_CR101","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2013.07.040","volume":"1531","author":"IH Shaik","year":"2013","unstructured":"Shaik IH, Miah MK, Bickel U, Mehvar R. Effects of short-term portacaval anastomosis on the peripheral and brain disposition of the blood-brain barrier permeability marker sodium fluorescein in rats. Brain Res. 2013;1531:84\u201393.","journal-title":"Brain Res"},{"issue":"1","key":"3901_CR102","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11011-024-01486-6","volume":"40","author":"MK Miah","year":"2024","unstructured":"Miah MK, Bickel U, Mehvar R. Bile duct ligation-induced cirrhosis does not alter the blood-brain barrier permeability to sucrose in rats. Metab Brain Dis. 2024;40(1):53.","journal-title":"Metab Brain Dis"},{"issue":"5","key":"3901_CR103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4174\/astr.2018.95.5.249","volume":"95","author":"NJ Yi","year":"2018","unstructured":"Yi NJ, Kim J, Choi Y, Kim H, Lee KB, Jang JJ, et al. Alteration of MRP2 expression and the graft outcome after liver transplantation. Ann Surg Treat Res. 2018;95(5):249\u201357.","journal-title":"Ann Surg Treat Res"},{"issue":"5","key":"3901_CR104","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.20886","volume":"42","author":"E Geuken","year":"2005","unstructured":"Geuken E, Visser DS, Leuvenink HG, de Jong KP, Peeters PM, Slooff MJ, et al. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients. Hepatology. 2005;42(5):1166\u201374.","journal-title":"Hepatology"},{"issue":"1","key":"3901_CR105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1478-3231.2011.02625.x","volume":"32","author":"GA Bernhardt","year":"2012","unstructured":"Bernhardt GA, Zollner G, Cerwenka H, Kornprat P, Fickert P, Bacher H, et al. Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy. Liver Int. 2012;32(1):119\u201327.","journal-title":"Liver Int"},{"issue":"9","key":"3901_CR106","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2217\/pgs-2018-0052","volume":"19","author":"DF Kisor","year":"2018","unstructured":"Kisor DF, Bodzin AS. Pharmacogenomics in liver transplantation: testing the recipient and the ex-vivo donor liver. Pharmacogenomics. 2018;19(9):753\u20136.","journal-title":"Pharmacogenomics"},{"issue":"1","key":"3901_CR107","doi-asserted-by":"publisher","first-page":"23508","DOI":"10.1038\/s41598-025-09296-1","volume":"15","author":"AD Ladd","year":"2025","unstructured":"Ladd AD, Angeli-Pahim I, Lewis D, Warren C, Nittu S, Lamba J, et al. Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation. Sci Rep. 2025;15(1):23508.","journal-title":"Sci Rep"},{"issue":"5","key":"3901_CR108","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/lt.20709","volume":"12","author":"W Wei-lin","year":"2006","unstructured":"Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, et al. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transpl. 2006;12(5):775\u201380.","journal-title":"Liver Transpl"},{"issue":"10","key":"3901_CR109","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1097\/TP.0000000000001394","volume":"100","author":"M Debette-Gratien","year":"2016","unstructured":"Debette-Gratien M, Woillard JB, Picard N, Sebagh M, Loustaud-Ratti V, Sautereau D, et al. Influence of donor and recipient CYP3A4, CYP3A5, and ABCB1 genotypes on clinical outcomes and nephrotoxicity in liver transplant recipients. Transplant. 2016;100(10):2129\u201337.","journal-title":"Transplant"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03901-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:09:46Z","timestamp":1756901386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03901-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":109,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03901-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}